# Nkarta, Inc.: filings

NKTX · Nasdaq · CIK 1787400 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nktx.md) · [Financials](/companies/nktx/financials.md) · [Filings](/companies/nktx/filings.md) · [Insiders](/companies/nktx/insiders.md)

## Reports and events: 114 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 183, 8-K 60, 3 31, 10-Q 19, SC 13G/A 16, SC 13G 12, SC 13D/A 10, CORRESP 9, UPLOAD 8, S-8 7, 10-K 6, DEF 14A 6, DEFA14A 6, 144 5, 424B5 5, SC 13D 5, ARS 4, EFFECT 4, SCHEDULE 13G/A 4, DRSLTR 3, S-1/A 3, S-3 3, SCHEDULE 13D/A 3, DRS/A 2, PRE 14A 2, 424B4 1, 4/A 1, 8-A12B 1, 8-K/A 1, CERT 1, D 1, DRS 1, S-1 1, S-1MEF 1, S-3/A 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-10 | 16:19 ET | [10-Q](/filings/0001787400-26-000017.md) | Quarterly report, period 2026-06-30 | 0001787400-26-000017 |
| 2026-08-10 | 16:12 ET | [8-K](/filings/0001193125-26-342402.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-342402 |
| 2026-06-11 | 16:59 ET | [8-K](/filings/0001193125-26-267830.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-267830 |
| 2026-05-19 | 16:03 ET | [SCHEDULE 13D/A](/filings/0001072613-26-000486.md) | Ownership report, active investor, amended | 0001072613-26-000486 |
| 2026-05-12 | 16:09 ET | [10-Q](/filings/0001787400-26-000013.md) | Quarterly report, period 2026-03-31 | 0001787400-26-000013 |
| 2026-05-12 | 16:04 ET | [8-K](/filings/0001787400-26-000012.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001787400-26-000012 |
| 2026-04-23 | 16:41 ET | [DEF 14A](/filings/0001140361-26-016403.md) | Proxy statement, period 2026-06-10 | 0001140361-26-016403 |
| 2026-03-26 | 17:55 ET | [8-K](/filings/0001787400-26-000008.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001787400-26-000008 |
| 2026-03-25 | 16:07 ET | [10-K](/filings/0001787400-26-000006.md) | Annual report, period 2025-12-31 | 0001787400-26-000006 |
| 2026-03-25 | 16:04 ET | [8-K](/filings/0001787400-26-000005.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001787400-26-000005 |
| 2025-11-24 | 18:48 ET | [SCHEDULE 13D/A](/filings/0001699737-25-000025.md) | Ownership report, active investor, amended | 0001699737-25-000025 |
| 2025-11-10 | 16:18 ET | [10-Q](/filings/0001193125-25-274304.md) | Quarterly report, period 2025-09-30 | 0001193125-25-274304 |
| 2025-11-10 | 16:13 ET | [8-K](/filings/0001193125-25-274261.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-274261 |
| 2025-08-12 | 16:17 ET | [10-Q](/filings/0001193125-25-178964.md) | Quarterly report, period 2025-06-30 | 0001193125-25-178964 |
| 2025-08-12 | 16:08 ET | [8-K](/filings/0001193125-25-178949.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-178949 |
| 2025-06-06 | 09:17 ET | [8-K](/filings/0000950170-25-082717.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-082717 |
| 2025-05-14 | 16:22 ET | [10-Q](/filings/0000950170-25-071455.md) | Quarterly report, period 2025-03-31 | 0000950170-25-071455 |
| 2025-05-14 | 16:14 ET | [8-K](/filings/0000950170-25-071399.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-071399 |
| 2025-04-21 | 16:19 ET | [DEF 14A](/filings/0001140361-25-014740.md) | Proxy statement, period 2025-06-05 | 0001140361-25-014740 |
| 2025-03-26 | 16:20 ET | [10-K](/filings/0000950170-25-045262.md) | Annual report, period 2024-12-31 | 0000950170-25-045262 |
| 2025-03-26 | 16:12 ET | [8-K](/filings/0000950170-25-045231.md) | 2.02 Results of operations; 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-045231 |
| 2025-02-12 | 16:30 ET | [SCHEDULE 13D/A](/filings/0000950170-25-018899.md) | Ownership report, active investor, amended | 0000950170-25-018899 |
| 2024-11-07 | 16:21 ET | [10-Q](/filings/0000950170-24-123395.md) | Quarterly report, period 2024-09-30 | 0000950170-24-123395 |
| 2024-11-07 | 16:11 ET | [8-K](/filings/0000950170-24-123340.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-123340 |
| 2024-08-16 | 19:12 ET | [8-K/A](/filings/0000950170-24-097741.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-097741 |
| 2024-08-13 | 16:08 ET | [10-Q](/filings/0000950170-24-096186.md) | Quarterly report, period 2024-06-30 | 0000950170-24-096186 |
| 2024-08-13 | 16:05 ET | [8-K](/filings/0000950170-24-096163.md) | 1.01 Entry into a material agreement | 0000950170-24-096163 |
| 2024-07-16 | 06:30 ET | [8-K](/filings/0000950170-24-083761.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-083761 |
| 2024-06-27 | 06:45 ET | [8-K](/filings/0000950170-24-078152.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-078152 |
| 2024-06-13 | 16:22 ET | [8-K](/filings/0000950170-24-073046.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-073046 |
| 2024-05-09 | 16:14 ET | [10-Q](/filings/0000950170-24-056980.md) | Quarterly report, period 2024-03-31 | 0000950170-24-056980 |
| 2024-05-09 | 16:04 ET | [8-K](/filings/0000950170-24-056870.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-056870 |
| 2024-04-25 | 16:31 ET | [DEF 14A](/filings/0001140361-24-022080.md) | Proxy statement, period 2024-06-13 | 0001140361-24-022080 |
| 2024-03-29 | 17:41 ET | [SC 13D/A](/filings/0001104659-24-041249.md) | Ownership report, active investor, amended | 0001104659-24-041249 |
| 2024-03-29 | 16:06 ET | [SC 13D/A](/filings/0001104659-24-041147.md) | Ownership report, active investor, amended | 0001104659-24-041147 |
| 2024-03-28 | 19:25 ET | [SC 13D/A](/filings/0001072613-24-000355.md) | Ownership report, active investor, amended | 0001072613-24-000355 |
| 2024-03-28 | 16:08 ET | [8-K](/filings/0000950170-24-038037.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-038037 |
| 2024-03-25 | 06:05 ET | [8-K](/filings/0000950170-24-035613.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-035613 |
| 2024-03-21 | 16:23 ET | [10-K](/filings/0000950170-24-034735.md) | Annual report, period 2023-12-31 | 0000950170-24-034735 |
| 2024-03-21 | 16:15 ET | [8-K](/filings/0000950170-24-034710.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-034710 |
| 2024-02-09 | 06:38 ET | [SC 13D/A](/filings/0001193125-24-029126.md) | Ownership report, active investor, amended | 0001193125-24-029126 |
| 2024-01-08 | 08:50 ET | [8-K](/filings/0000950170-24-002733.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-002733 |
| 2023-11-09 | 16:19 ET | [10-Q](/filings/0000950170-23-062091.md) | Quarterly report, period 2023-09-30 | 0000950170-23-062091 |
| 2023-11-09 | 16:06 ET | [8-K](/filings/0000950170-23-062019.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-062019 |
| 2023-10-17 | 07:06 ET | [8-K](/filings/0000950170-23-053645.md) | 2.02 Results of operations; 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-053645 |
| 2023-10-16 | 16:07 ET | [8-K](/filings/0000950170-23-053528.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-053528 |
| 2023-08-10 | 07:15 ET | [10-Q](/filings/0000950170-23-040953.md) | Quarterly report, period 2023-06-30 | 0000950170-23-040953 |
| 2023-08-10 | 07:05 ET | [8-K](/filings/0000950170-23-040948.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-040948 |
| 2023-07-05 | 16:09 ET | [8-K](/filings/0000950170-23-031624.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-031624 |
| 2023-06-27 | 07:07 ET | [8-K](/filings/0000950170-23-029955.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-029955 |

Page 1 of 3. [Older](/companies/nktx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.